ABL, Bio

ABL Bio anuncia un acuerdo de licencia con GSK para la plataforma de administración cerebral Grabody-B

Published on 08/07/2025 at 18:08 | prnewswire.co.uk

ABL Bio, Inc. Algeria Bahrain Egypt Iran Iraq Jordan Kuwait Lebanon Libya Morocco Oman Qatar Saudi Arabia Syria Tunisia United Arab Emirates Yemen Angola Botswana Ethiopia Gambia Ghana Guinea-Bissau Kenya Lesotho Liberia Malawi Maldives Mozambique Namibia Nigeria Sierra Leone Somalia South Africa Swaziland Tanzania Uganda Zambia Zimbabwe South Korea New York

en | boerse | 67932979 |